Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.8.0.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - 3 months ended Mar. 31, 2018 - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 5,560 $ 123,476,102 $ (65,698,101) $ 57,783,561
Balance, shares at Dec. 31, 2017 55,603,427      
Issuance of common stock, net of issuance costs of $505,368 $ 150 11,194,482 11,194,632
Issuance of common stock, net of issuance costs of $505,368, shares 1,500,000      
Stock-based compensation expense 1,884,916 1,884,916
Issuance of common stock upon exercise of stock options $ 4 156,651 $ 156,655
Issuance of common stock upon exercise of stock options, shares 36,465     36,465
Fair value of warrant issued in connection with Investment Agreement 6,215,225 $ 6,215,225
Net loss     (11,695,385) (11,695,385)
Balance at Mar. 31, 2018 $ 5,714 $ 142,927,376 $ (77,393,486) $ 65,539,604
Balance, shares at Mar. 31, 2018 57,139,892